Satraplatine for use in the treatment of primary central nervous system lymphoma (PCNSL)
AL13697BActive Publication Date: 2026-09-23PHARMA& SCHWEIZ GMBH
0 Cites 0 Cited by
Patent Information
- Application Number
- AL2026321
- Authority / Receiving Office
- AL · AL
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2026-05-20
- Publication Date
- 2026-09-23
- Estimated Expiration
- 2046-05-20
Need to check novelty before this filing date? Find Prior Art
No text content released.